Palvella Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Palvella intends to use the net proceeds from this offering to support the development of its programs, including QTORIN rapamycin and QTORIN pitavastatin, and for working capital and other general ...

Earnings live: MongoDB stock tumbles, Norwegian Cruise Line sinks, with Target earnings on deck

The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far ...

Greggs: A Discounted Opportunity Heading Into Earnings

Greggs shares look cheap at a low P/E and 4%+ yield; March 3 earnings could be a catalyst. Click here to read my latest analysis of GGGSF stock.

Before You Buy Any Stock, Run This 4-Step Reality Check

Numbers, Edge, X-risks, Thesis—is useful to pick better stocks. Read why Union Pacific passes and PayPal fails in this framework.

Ramaco Resources, Inc.: Ramaco Resources Reports Fourth Quarter And Full-year 2025 Results

Ramaco Resources, Inc. (NASDAQ: METC, METCB, "Ramaco" or the "Company") is a leading operator and developer of high-quality ...